Tasigna and Cirrhosis alcoholic - a phase IV clinical study of FDA data
Summary:
Cirrhosis alcoholic is reported only by a few people who take Tasigna.
The phase IV clinical study analyzes which people take Tasigna and have Cirrhosis alcoholic. It is created by eHealthMe based on reports of 28,511 people who have side effects while taking Tasigna from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
28,511 people reported to have side effects when taking Tasigna.
Among them, 2 people (0.01%) have Cirrhosis alcoholic.
What is Tasigna?
Tasigna has active ingredients of nilotinib hydrochloride monohydrate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 26,536 Tasigna users for its effectiveness, alternative drugs and more.
What is Cirrhosis alcoholic?
Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism) is found to be associated with 363 drugs and 162 conditions by eHealthMe.
Number of Tasigna and Cirrhosis alcoholic reports submitted per year:

Gender of people who have Cirrhosis alcoholic when taking Tasigna *:
- female: 0.0 %
- male: 100 %
Age of people who have Cirrhosis alcoholic when taking Tasigna *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common drugs people take besides Tasigna *:
- Mefenamic Acid: 1 person, 50.00%
Common side effects people have besides Cirrhosis alcoholic *:
- Liver Disorder (liver diseases): 1 person, 50.00%
- Hepatorenal Failure (decrease in kidney function in a person with a severe liver disorder): 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Tasigna and have Cirrhosis alcoholic?
Check whether Cirrhosis alcoholic is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Cirrhosis alcoholic and when was it recovered:
Expand to all the drugs that have ingredients of nilotinib hydrochloride monohydrate:
Alternative drugs to, pros and cons of Tasigna:
- Tasigna (26,536 reports)
Common Tasigna side effects:
- Abdominal discomfort: 339 reports
- Abdominal distension: 289 reports
- Abdominal pain: 768 reports
- Abdominal pain upper: 877 reports
- Acne (skin problems that cause pimples): 255 reports
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 120 reports
- Acute kidney failure: 263 reports
- Acute myocardial infarction (acute heart attack): 277 reports
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 234 reports
- Alanine aminotransferase increased: 273 reports
- Anaemia (lack of blood): 959 reports
- Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat): 660 reports
- Arrhythmias (irregular heartbeat): 359 reports
- Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked): 107 reports
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 129 reports
- Ascites (accumulation of fluid in the abdominal cavity): 123 reports
- Aspartate aminotransferase increased: 212 reports
- Atherosclerosis (disorder of the arteries): 311 reports
- Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 446 reports
- Back pain: 692 reports
- Blast crisis in myelogenous leukaemia: 202 reports
- Blindness: 103 reports
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 111 reports
- Blockage of leg arteries: 190 reports
- Blood alkaline phosphatase increased: 111 reports
- Blood bilirubin increased: 422 reports
- Blood creatine phosphokinase increased: 137 reports
- Blood creatinine increased: 253 reports
- Blood glucose increased: 478 reports
- Blood lactate dehydrogenase increased: 111 reports
- Bone marrow failure: 141 reports
- Bone pain: 603 reports
- Breathing difficulty: 1,491 reports
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 168 reports
- Burning sensation: 157 reports
- Cardiac arrest: 176 reports
- Cardiac disorder: 272 reports
- Cardiac failure: 333 reports
- Cardiac failure congestive: 196 reports
- Carotid artery stenosis (narrowing of carotid artery): 107 reports
- Cataract (clouding of the lens inside the eye): 124 reports
- Cellulitis (infection under the skin): 101 reports
- Cerebral infarction (less blood supply to brain resulting tissue damage): 184 reports
- Chest pain: 1,077 reports
- Chills (felling of cold): 208 reports
- Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 652 reports
- Chronic myeloid leukaemia transformation (cancer of blood forming cells spreads to blood cells): 106 reports
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe): 142 reports
- Confusional state: 146 reports
- Constipation: 620 reports
- Coronary artery stenosis (narrowing of coronary artery): 188 reports
- Coronary heart disease (narrowing or blockage of the coronary arteries): 456 reports
- Cough: 717 reports
- C-reactive protein increased: 113 reports
- Death: 2,720 reports
- Dehydration (dryness resulting from the removal of water): 160 reports
- Depressed mood: 128 reports
- Depression: 288 reports
- Diabetes: 401 reports
- Diarrhea: 1,017 reports
- Discomfort: 145 reports
- Disease progression: 106 reports
- Dizziness: 969 reports
- Drowsiness: 241 reports
- Drug ineffective: 732 reports
- Drug intolerance (drug sensitivity): 325 reports
- Drug resistance (reduction in effectiveness of a drug): 149 reports
- Dry mouth: 107 reports
- Dry skin: 403 reports
- Dyspnea exertional: 117 reports
- Ear pain: 115 reports
- Electrocardiogram qt prolonged: 961 reports
- Eye pain: 105 reports
- Fainting (loss of consciousness and postural tone): 210 reports
- Fall: 360 reports
- Fatigue (feeling of tiredness): 2,181 reports
- Fever: 1,214 reports
- Flatulence (flatus expelled through the anus): 123 reports
- Fluid retention (an abnormal accumulation of fluid in the blood): 239 reports
- Gait disturbance: 443 reports
- Gallstones (stone formation by bile component): 147 reports
- Gamma-glutamyltransferase increased: 159 reports
- Gastric ulcer (stomach ulcer): 136 reports
- Gastritis (inflammation of stomach): 156 reports
- Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 278 reports
- Gastrointestinal disorder (functional problems of gastrointestinal tract): 132 reports
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract): 121 reports
- General physical health deterioration (weak health status): 322 reports
- Haemoglobin decreased: 690 reports
- Haemorrhage (bleeding): 133 reports
- Hair loss: 654 reports
- Headache (pain in head): 1,483 reports
- Head injury: 250 reports
- Heart attack: 896 reports
- Heart disease: 117 reports
- Heart palpitations (feelings or sensations that your heart is pounding or racing): 362 reports
- Heart rate increased: 127 reports
- Hepatic enzyme increased: 194 reports
- High blood cholesterol: 374 reports
- High blood pressure: 776 reports
- Hyperbilirubinaemia (excess of bilirubin in the blood): 102 reports
- Hyperglycemia (high blood sugar): 271 reports
- Hyperhidrosis (abnormally increased sweating): 248 reports
- Hyperkalemia (damage to or disease of the kidney): 106 reports
- Hyperlipidaemia (presence of excess lipids in the blood): 116 reports
- Hypersensitivity: 249 reports
- Hypoacusis (loss of hearing): 156 reports
- Hypoaesthesia (reduced sense of touch or sensation): 383 reports
- Hypotension (abnormally low blood pressure): 252 reports
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 144 reports
- Indigestion: 384 reports
- Infection: 267 reports
- Inflammation: 146 reports
- Insomnia (sleeplessness): 388 reports
- Itching: 1,127 reports
- Jaundice - yellow skin (a yellowish pigmentation of the skin): 132 reports
- Joint pain: 940 reports
- Joint swelling: 106 reports
- Kidney stones: 119 reports
- Leukaemia (blood or bone marrow cancer): 126 reports
- Leukocytosis (increased white blood cells): 174 reports
- Leukopenia (less number of white blood cells in blood): 137 reports
- Lipase increased: 321 reports
- Liver disorder (liver diseases): 202 reports
- Loss of consciousness: 236 reports
- Lung disorder (lung disease): 118 reports
- Malaise (a feeling of general discomfort or uneasiness): 1,078 reports
- Malignant neoplasm progression (cancer tumour came back): 552 reports
- Maternal exposure during pregnancy (use of substance during pregnancy): 184 reports
- Memory loss: 354 reports
- Migraine (headache): 101 reports
- Mitral valve incompetence (inefficient heart valve): 101 reports
- Muscle aches (muscle pain): 676 reports
- Muscle spasms (muscle contraction): 612 reports
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 252 reports
- Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 161 reports
- Nasopharyngitis (inflammation of the nasopharynx): 445 reports
- Nausea (feeling of having an urge to vomit): 1,599 reports
- Nausea and vomiting: 1,007 reports
- Neck pain: 185 reports
- Neoplasm malignant (cancer tumour): 309 reports
- Neuropathy peripheral (surface nerve damage): 148 reports
- Nosebleed (bleeding from nose): 138 reports
- Oedema (fluid collection in tissue): 202 reports
- Oedema peripheral (superficial swelling): 388 reports
- Oropharyngeal pain: 170 reports
- Pain: 1,202 reports
- Pain in extremity: 1,073 reports
- Pancreatitis (inflammation of pancreas): 386 reports
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 316 reports
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 211 reports
- Pericardial effusion (fluid around the heart): 188 reports
- Peripheral arterial occlusive disease (reproducible ischemic muscle pain): 434 reports
- Peripheral swelling: 291 reports
- Peripheral vascular disorder: 223 reports
- Platelet count increased: 162 reports
- Pleural effusion (water on the lungs): 652 reports
- Pneumonia: 729 reports
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 108 reports
- Productive cough: 103 reports
- Pruritus generalised (generalized itching): 119 reports
- Pulmonary oedema (fluid accumulation in the lungs): 198 reports
- Rashes (redness): 2,191 reports
- Rash pruritic (redness with itching): 163 reports
- Red blood cell count decreased: 159 reports
- Renal disorder (kidney disease): 104 reports
- Renal impairment (severely reduced kidney function): 151 reports
- Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 126 reports
- Second primary malignancy (after getting cure a cancer, a new cancer development): 344 reports
- Sepsis (a severe blood infection that can lead to organ failure and death): 198 reports
- Sinusitis (inflammation of sinus): 127 reports
- Skin disorder (skin disease): 198 reports
- Sleep disorder: 126 reports
- Speech disorder: 117 reports
- Speech impairment (adult) (inability to speak (adult)): 148 reports
- Splenomegaly (enlargement of spleen): 242 reports
- Stable angina (a constant chest pain): 490 reports
- Stress and anxiety: 627 reports
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 590 reports
- Swallowing difficulty: 183 reports
- Swelling: 206 reports
- Swelling face: 109 reports
- The flu (the flu is caused by an influenza virus): 349 reports
- Therapeutic response decreased (less preventive response): 128 reports
- Thrombocytopenia (decrease of platelets in blood): 1,471 reports
- Thrombosis (formation of a blood clot inside a blood vessel): 137 reports
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 141 reports
- Tremor (trembling or shaking movements in one or more parts of your body): 135 reports
- Urinary tract infection: 250 reports
- Urticaria (rash of round, red welts on the skin that itch intensely): 142 reports
- Vision blurred: 213 reports
- Visual impairment: 205 reports
- Weakness: 1,186 reports
- Weight decreased: 672 reports
- Weight increased: 355 reports
- White blood cell count decreased: 449 reports
- White blood cell count increased: 483 reports
Browse all side effects of Tasigna:
a b c d e f g h i j k l m n o p q r s t u v w x y zCirrhosis alcoholic treatments and more:
- Cirrhosis alcoholic (749 reports)
COVID vaccines that are related to Cirrhosis alcoholic:
- Cirrhosis alcoholic in Moderna COVID Vaccine
- Cirrhosis alcoholic in Pfizer BioNTech Covid Vaccine
- Cirrhosis alcoholic in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Cirrhosis alcoholic:
- Cirrhosis alcoholic (363 drugs)
All the conditions that are associated with Cirrhosis alcoholic:
- Cirrhosis alcoholic (162 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on nilotinib hydrochloride monohydrate (the active ingredients of Tasigna) and Tasigna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- How effective is Remicade for Colitis? - 9 seconds ago
- Flomax and Large Intestinal Haemorrhage - 15 seconds ago
- Vitamin D and Lymphocyte Count Increased - 33 seconds ago
- Demadex and Fainting - 35 seconds ago
- Novalgin and Bladder Cancer - 37 seconds ago
- Hydrocortisone and Pulmicort drug interaction - 37 seconds ago
- Aldurazyme and Skull Fracture - 39 seconds ago
- Subutex and Muscle Atrophy - 46 seconds ago
- Aygestin and Acute Myocardial Infarction - 58 seconds ago
- Vitamins and Retinopathy Of Prematurity - a minute ago